19-13919829-A-G

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_017721.5(CC2D1A):​c.1234A>G​(p.Ile412Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00277 in 1,603,876 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I412M) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0024 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0028 ( 5 hom. )

Consequence

CC2D1A
NM_017721.5 missense

Scores

5
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:4

Conservation

PhyloP100: 3.18

Publications

5 publications found
Variant links:
Genes affected
CC2D1A (HGNC:30237): (coiled-coil and C2 domain containing 1A) This gene encodes a transcriptional repressor that binds to a conserved 14-bp 5'-repressor element and regulates expression of the 5-hydroxytryptamine (serotonin) receptor 1A gene in neuronal cells. The DNA binding and transcriptional repressor activities of the protein are inhibited by calcium. A mutation in this gene results in a nonsyndromic form of cognitive disability (MRT3). [provided by RefSeq, Jul 2017]
CC2D1A Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • intellectual disability, autosomal recessive 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • autosomal recessive non-syndromic intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010265142).
BP6
Variant 19-13919829-A-G is Benign according to our data. Variant chr19-13919829-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 210590.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00242 (368/152252) while in subpopulation AMR AF = 0.0053 (81/15290). AF 95% confidence interval is 0.00437. There are 0 homozygotes in GnomAd4. There are 173 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CC2D1ANM_017721.5 linkc.1234A>G p.Ile412Val missense_variant Exon 12 of 29 ENST00000318003.11 NP_060191.3 Q6P1N0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CC2D1AENST00000318003.11 linkc.1234A>G p.Ile412Val missense_variant Exon 12 of 29 1 NM_017721.5 ENSP00000313601.6 Q6P1N0-1

Frequencies

GnomAD3 genomes
AF:
0.00242
AC:
368
AN:
152134
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00113
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00530
Gnomad ASJ
AF:
0.00634
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00113
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00298
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.00238
AC:
590
AN:
248050
AF XY:
0.00237
show subpopulations
Gnomad AFR exome
AF:
0.00110
Gnomad AMR exome
AF:
0.00405
Gnomad ASJ exome
AF:
0.00391
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00121
Gnomad NFE exome
AF:
0.00300
Gnomad OTH exome
AF:
0.00415
GnomAD4 exome
AF:
0.00281
AC:
4075
AN:
1451624
Hom.:
5
Cov.:
30
AF XY:
0.00275
AC XY:
1978
AN XY:
720566
show subpopulations
African (AFR)
AF:
0.000844
AC:
28
AN:
33166
American (AMR)
AF:
0.00378
AC:
167
AN:
44230
Ashkenazi Jewish (ASJ)
AF:
0.00412
AC:
107
AN:
26000
East Asian (EAS)
AF:
0.0000254
AC:
1
AN:
39408
South Asian (SAS)
AF:
0.000244
AC:
21
AN:
85926
European-Finnish (FIN)
AF:
0.000769
AC:
41
AN:
53316
Middle Eastern (MID)
AF:
0.00247
AC:
11
AN:
4454
European-Non Finnish (NFE)
AF:
0.00319
AC:
3521
AN:
1105372
Other (OTH)
AF:
0.00298
AC:
178
AN:
59752
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
188
376
564
752
940
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
138
276
414
552
690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00242
AC:
368
AN:
152252
Hom.:
0
Cov.:
32
AF XY:
0.00232
AC XY:
173
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.00113
AC:
47
AN:
41556
American (AMR)
AF:
0.00530
AC:
81
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00634
AC:
22
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00113
AC:
12
AN:
10604
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00298
AC:
203
AN:
68014
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
20
41
61
82
102
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00261
Hom.:
5
Bravo
AF:
0.00273
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00234
AC:
9
ESP6500AA
AF:
0.000803
AC:
3
ESP6500EA
AF:
0.00280
AC:
23
ExAC
AF:
0.00204
AC:
246
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00405
EpiControl
AF:
0.00451

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CC2D1A: BP4 -

Sep 27, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Intellectual disability, autosomal recessive 3 Uncertain:2
Mar 05, 2018
Genomic Research Center, Shahid Beheshti University of Medical Sciences
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 07, 2019
Baylor Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -

not specified Uncertain:1
Aug 08, 2014
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Uncertain:1
May 27, 2020
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.I412V variant (also known as c.1234A>G), located in coding exon 12 of the CC2D1A gene, results from an A to G substitution at nucleotide position 1234. The isoleucine at codon 412 is replaced by valine, an amino acid with highly similar properties. This variant has co-occurred with variants in other intellectual disability (ID)-related genes in individuals from an ID cohort (Grozeva D et al. Hum. Mutat., 2015 Dec;36:1197-204). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

CC2D1A-related disorder Benign:1
Mar 18, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.16
T;.
Eigen
Benign
-0.0039
Eigen_PC
Benign
0.11
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.91
D;D
M_CAP
Benign
0.017
T
MetaRNN
Benign
0.010
T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Uncertain
2.6
M;M
PhyloP100
3.2
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-0.82
N;.
REVEL
Benign
0.070
Sift
Uncertain
0.018
D;.
Sift4G
Benign
0.093
T;T
Polyphen
0.10
B;B
Vest4
0.15
MVP
0.34
MPC
0.31
ClinPred
0.031
T
GERP RS
4.9
PromoterAI
-0.018
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.098
gMVP
0.11
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs191830054; hg19: chr19-14030642; API